Phenylketonuria Treatment Market Trends

The growing prevalence of PKU is significantly driving the expansion of the PKU treatment market. As more cases are diagnosed, there is an increased demand for effective treatment solutions to manage this metabolic disorder.

• For instance, according to the National Institutes of Health (NIH) in 2023, approximately 1 in 10,000 to 15,000 newborns worldwide are diagnosed with PKU, highlighting a substantial global incidence rate. This increasing prevalence underscored the critical need for effective treatment solutions and comprehensive management strategies for PKU patients thereby expanding the market adoption.
  
• Thus, as more cases are identified due to enhanced newborn screening and greater awareness, there is an increasing need for effective management solutions. This rise in prevalence necessitated a demand for effective treatment options, including new drugs and advanced therapies, to address the growing patient population further drives the market demand.